+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sleep Apnea Devices Market Size, Share & Trends Analysis Report by Product Type (Therapeutic, Diagnostic), by Region (North America, Europe, APAC, LATAM, MEA), and Segment Forecasts, 2020 - 2027

  • ID: 3292581
  • Report
  • March 2020
  • Region: North America, Europe, Asia Pacific
  • 100 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BMC Medical Co. Ltd.
  • Compumedics Limited
  • GE Healthcare
  • Invacare Corporation
  • Natus Medical Inc.
  • Philips Respironics
  • MORE
The global sleep apnea devices market size is projected to reach USD 10.3 billion by 2027, expanding at a CAGR of 7.4% over the forecast period. Increasing number of patients suffering from obstructive sleep apnea (OSA) is a key factor expected to drive the market growth. Furthermore, growing awareness about the condition and related comorbidities is likely to drive the growth over the forecast period. However, high cost of diagnosis and treatment for sleeping disorders is one of the key factors anticipated to restrain the market growth.

Based on product type, the market is segmented into diagnostic and therapeutic devices. In 2019, the therapeutic devices segment dominated the market with a revenue share of 64.1%. The penetration of these devices has grown at a lucrative rate over the past few years, owing to promising reimbursement guidelines in various countries. Moreover, availability of technologically advanced and innovative products has enhanced the growth of this segment. On the other hand, the diagnostic device segment is expected to grow at the fastest rate over the forecast period, owing to a rise in the number of patients diagnosed with respiratory disorders.

Based on region, North America dominated the market in 2019 with a revenue share of 51.5%. Presence of major market participants and rising awareness related to sleeping disorders and associated diseases in the region has reinforced the sleep apnea devices industry growth in the region. On the other hand, the Asia Pacific region is expected to grow at the fastest CAGR over the forecast period, owing to rising prevalence of geriatric population suffering from sleep disorders and establishment of sleep laboratory facilities for testing sleep apnea patients.

Further key findings from the report suggest:
  • The therapeutic devices segment accounted for a major revenue share of 64.1% in 2019 owing to the availability of technologically advanced products
  • The diagnostic devices segment is expected to witness a lucrative growth rate of 7.6% owing to increasing number of patients diagnosed with respiratory disorders and rising awareness regarding the disease
  • North America dominated the market in 2019, owing to increasing awareness related to obstructive sleep apnea (OSA) and associated comorbidities in the region
  • Some of the key players in the sleep apnea devicesmarket are Curative Medical Inc., Philips Respironics, ResMed, Fisher & Paykel Healthcare, Cadwell Laboratories, and Invacare Corporation.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BMC Medical Co. Ltd.
  • Compumedics Limited
  • GE Healthcare
  • Invacare Corporation
  • Natus Medical Inc.
  • Philips Respironics
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.4.1 Region Market: CAGR Calculation
1.5 Region Based Segment Share Calculation
1.6 List Of Secondary Sources
1.7 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot, Revenue (USD Million)

Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Sleep Apnea Devices Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraints Analysis
3.2.3 Industry Challenge
3.3 Sleep Apnea Devices Market Analysis Tools
3.3.1.Industry Analysis - Porter’s
3.3.1.1.Supplier Power
3.3.1.2.Buyer Power
3.3.1.3.Substitution Threat
3.3.1.4.Threat From New Entrant
3.3.1.5.Competitive Rivalry
3.3.2.PESTEL Analysis
3.3.2.1.Political Landscape
3.3.2.2.Environmental Landscape
3.3.2.3.Social Landscape
3.3.2.4.Technology Landscape
3.3.2.5.Legal Landscape
3.4 Regulatory Framework
3.4.1.Compliance Standards of PAP Devices for Key Countries
3.4.1.1.Manufacturing Compliances
3.4.1.2.Payer Compliances
3.4.1.3.Patient Compliances
3.5 Prevalence Of Obstructive Sleep Apnea (OSA) By Country, 2016 - 2027
3.6 Incidence Of Obstructive Sleep Apnea (OSA) By Country, 2016 - 2027
3.7 Product Pipeline Analysis

Chapter 4 Sleep Apnea Devices Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Market Position Analysis
4.3 Company Market Share Analysis, 2019
4.4 Market Differentiators
4.5 List of Key Emerging Companies

Chapter 5 Sleep Apnea Devices Market: Product Type Market Estimates & Trend Analysis
5.1. Product Type Market Movement Analysis & Market Share, 2019 & 2027
5.2. Market Revenue Size & Forecasts and Trend Analysis, 2016 to 2027 for the Following Product Types:
5.2.1.Diagnostic Devices
5.2.1.1. Actigraphs
5.2.1.2. Polysomnography (PSG) Device
5.2.1.3. Respiratory Polygraphs
5.2.1.4. Pulse Oximeters
5.2.2. Therapeutic Devices
5.2.2.1. Positive Airway Pressure (PAP) Devices
5.2.2.1.1. CPAP
5.2.2.1.2. APAP
5.2.2.1.3. Bi-PAP
5.2.2.2. Oral Devices
5.2.2.3. Nasal Devices
5.2.2.4. Chin Straps

Chapter 6 Sleep Apnea Devices Market: Regional Estimates & Trend Analysis by Product Type
6.1. Regional Market Snapshot (Market Size, CAGR, Key Players, Key Trends)
6.2. Market Size & Forecasts, and Trend Analysis, 2019 to 2027
6.2.1. North America
6.2.1.1. U.S.
6.2.1.2. Canada
6.2.2. Europe
6.2.2.1. U.K.
6.2.2.2. Germany
6.2.2.3. Spain
6.2.2.4. France
6.2.2.5. Italy
6.2.2.6. Russia
6.2.3. Asia Pacific
6.2.3.1. China
6.2.3.2. Japan
6.2.3.3. India
6.2.3.4. South Korea
6.2.3.5. Singapore
6.2.3.6. Australia
6.2.4. Latin America
6.2.4.1. Brazil
6.2.4.2. Argentina
6.2.4.3. Mexico
6.2.5. Middle East & Africa (MEA)
6.2.5.1. South Africa
6.2.5.2. Saudi Arabia
6.2.5.3. UAE

Chapter 7 Competitive Landscape
7.1. Company Profiles
7.1.1. BMC Medical Co. Ltd.
7.1.1.1. Company overview
7.1.1.2. Financial Performance
7.1.1.3. Product benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Braebon Medical Corporation
7.1.2.1. Company overview
7.1.2.2. Financial Performance
7.1.2.3. Product benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Carefusion Corp
7.1.3.1. Company overview
7.1.3.2. Financial Performance
7.1.3.3. Product benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Compumedics Limited
7.1.4.1. Company overview
7.1.4.2. Financial Performance
7.1.4.3. Product benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Curative Medical Inc.
7.1.5.1. Company overview
7.1.5.2. Financial Performance
7.1.5.3. Product benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Fisher & Paykel Healthcare
7.1.6.1. Company overview
7.1.6.2. Financial Performance
7.1.6.3. Product benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. GE Healthcare
7.1.7.1. Company overview
7.1.7.2. Financial Performance
7.1.7.3. Product benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. ImThera Medical Inc.
7.1.8.1. Company overview
7.1.8.2. Financial Performance
7.1.8.3. Product benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Invacare Corporation
7.1.9.1. Company overview
7.1.9.2. Financial Performance
7.1.9.3. Product benchmarking
7.1.9.4.Strategic Initiatives
7.1.10. Itamar Medical Ltd.
7.1.10.1.Company overview
7.1.10.2.Financial Performance
7.1.10.3.Product benchmarking
7.1.10.4.Strategic Initiatives
7.1.11. Natus Medical Inc.
7.1.11.1. Company overview
7.1.11.2. Financial Performance
7.1.11.3. Product benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. Nihon Kohden
7.1.12.1. Company overview
7.1.12.2. Financial Performance
7.1.12.3. Product benchmarking
7.1.12.4. Strategic Initiatives
7.1.13. Philips Respironics
7.1.13.1. Company overview
7.1.13.2. Financial Performance
7.1.13.3. Product benchmarking
7.1.13.4. Strategic Initiatives
7.1.14. ResMed Inc.
7.1.14.1. Company overview
7.1.14.2. Financial Performance
7.1.14.3. Product benchmarking
7.1.14.4. Strategic Initiatives
7.1.15. Somnetics International Inc.
7.1.15.1. Company overview
7.1.15.2. Financial Performance
7.1.15.3. Product benchmarking
7.1.15.4. Strategic Initiatives
7.1.16. SOMNOmedics GmbH
7.1.16.1. Company overview
7.1.16.2. Financial Performance
7.1.16.3. Product benchmarking
7.1.16.4. Strategic Initiatives
7.1.17. Teleflex Inc.
7.1.17.1. Company overview
7.1.17.2. Financial Performance
7.1.17.3. Product benchmarking
7.1.17.4. Strategic Initiatives
7.1.18. Weinmann Medical Devices GmbH & Co. KG.
7.1.18.1. Company overview
7.1.18.2. Financial Performance
7.1.18.3. Product benchmarking
7.1.18.4. Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 4
  • BMC Medical Co. Ltd.
  • Braebon Medical Corporation
  • Carefusion Corp
  • Compumedics Limited
  • Curative Medical Inc.
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • ImThera Medical Inc.
  • Invacare Corporation
  • Itamar Medical Ltd.
  • Natus Medical Inc.
  • Nihon Kohden
  • Philips Respironics
  • ResMed Inc.
  • Somnetics International Inc.
  • SOMNOmedics GmbH
  • Teleflex Inc.
  • Weinmann Medical Devices GmbH & Co. KG.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll